Self-referral ban to free up huge new market
publication date: May 17, 2010
The German lab market for private operators should soar in 2014 when specialists will be forbidden from carrying out their own tests. Arne Hartmann at General Atlantic, an investor in Almedes, a big German lab group, reckons that no fewer than €1bn of tests are self-referred in this way.
To get full access to this article you will need to subscribe to Healthcare Europa. This gives you indepth quality coverage of how the dynamic private healthcare sector is developing across Europe.
Please click here to look at subscription options.
You can, however, register for free to recieve limited access. This gives you access to headlines and the first lines of stories and you can ask us to send you a news email with headlines 40 times a year. As a free registrant, you can also view our blog. Click here to sign up for limited access free registration.
